
#114 What Are the Generic and Biosimilar Industries Worried About? Current Competition Law Issues Impacting the Sector.
Generics and biosimilars are an important part of the pharmaceutical landscape in Europe. What are […]
Posted 1 year ago Tagged biosimilars comfort letter COVID denigration divisional patents European Commission generics patent linkage pharmaceuticals
Generics and biosimilars are an important part of the pharmaceutical landscape in Europe. What are […]
Posted 2 years ago Tagged antitrust biologics daraprim patent wars pay-for-delay pharmaceutical antitrust pharmaceuticals
Although there is little question as to the need for affordable, accessible, and high-quality pharmaceuticals, […]